Paul Matteis
Stock Analyst at Stifel Nicolaus
(4.83)
# 459
Out of 4,453 analysts
701
Total ratings
53.7%
Success rate
17.6%
Average return
Main Sectors:
Stocks Rated by Paul Matteis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics | Maintained: Buy | $30 | $44.79 | -33.02% | 3 | Jun 22, 2026 | |
| QURE uniQure | Maintained: Buy | $28 → $71 | $49.10 | +44.60% | 26 | Jun 21, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $133 | $108.26 | +22.85% | 12 | Jun 15, 2026 | |
| SPTX Seaport Therapeutics | Reiterated: Buy | $30 | $19.55 | +53.45% | 2 | Jun 9, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $28 → $36 | $31.96 | +12.64% | 4 | Jun 2, 2026 | |
| IMUX Immunic | Maintained: Buy | $25 | $15.07 | +65.89% | 3 | May 28, 2026 | |
| SION Sionna Therapeutics | Maintained: Buy | $55 | $42.77 | +28.59% | 4 | May 25, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Hold | $68 | $57.35 | +18.57% | 44 | May 24, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $46 | $30.41 | +51.27% | 23 | May 13, 2026 | |
| NMRA Neumora Therapeutics | Maintained: Hold | $3 | $1.51 | +98.68% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $17 | $4.69 | +262.47% | 8 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $38.91 | +43.92% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $45 | $52.83 | -14.82% | 57 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 → $86 | $56.78 | +51.46% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $28 | $13.29 | +110.68% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $23.72 | +1.18% | 48 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $188 | $164.18 | +14.51% | 54 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $466 | $480.18 | -2.95% | 41 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $83 → $86 | $78.34 | +9.78% | 32 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $214 | $201.96 | +5.96% | 50 | Apr 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $1.71 | +601.75% | 17 | Apr 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $25.30 | +30.43% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $24.73 | +65.79% | 28 | Mar 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $30.97 | +29.16% | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $14 | $13.58 | +3.09% | 6 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $25.34 | +26.28% | 10 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.6166 | +62.18% | 7 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $508 → $444 | $293.17 | +51.45% | 46 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.85 | - | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.21 | +352.49% | 9 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $36 | $20.61 | +74.67% | 26 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.55 | n/a | 11 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $12.66 | n/a | 11 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $5.75 | n/a | 13 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $20 | $70.16 | n/a | 4 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.0001 | n/a | 1 | Aug 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $20 | $0.0001 | n/a | 4 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.45 | n/a | 1 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.87 | n/a | 4 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $17.39 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.0004 | n/a | 3 | May 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $7 | $1.05 | n/a | 2 | May 6, 2016 |
Definium Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $30
Current: $44.79
Upside: -33.02%
uniQure
Jun 21, 2026
Maintained: Buy
Price Target: $28 → $71
Current: $49.10
Upside: +44.60%
Rhythm Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: $133
Current: $108.26
Upside: +22.85%
Seaport Therapeutics
Jun 9, 2026
Reiterated: Buy
Price Target: $30
Current: $19.55
Upside: +53.45%
MapLight Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: $28 → $36
Current: $31.96
Upside: +12.64%
Immunic
May 28, 2026
Maintained: Buy
Price Target: $25
Current: $15.07
Upside: +65.89%
Sionna Therapeutics
May 25, 2026
Maintained: Buy
Price Target: $55
Current: $42.77
Upside: +28.59%
BioMarin Pharmaceutical
May 24, 2026
Maintained: Hold
Price Target: $68
Current: $57.35
Upside: +18.57%
Neurogene
May 13, 2026
Reiterated: Buy
Price Target: $46
Current: $30.41
Upside: +51.27%
Neumora Therapeutics
May 12, 2026
Maintained: Hold
Price Target: $3
Current: $1.51
Upside: +98.68%
May 12, 2026
Maintained: Buy
Price Target: $21 → $17
Current: $4.69
Upside: +262.47%
May 12, 2026
Maintained: Buy
Price Target: $56
Current: $38.91
Upside: +43.92%
May 8, 2026
Maintained: Buy
Price Target: $42 → $45
Current: $52.83
Upside: -14.82%
May 8, 2026
Maintained: Buy
Price Target: $89 → $86
Current: $56.78
Upside: +51.46%
May 8, 2026
Maintained: Buy
Price Target: $29 → $28
Current: $13.29
Upside: +110.68%
May 7, 2026
Reiterated: Hold
Price Target: $24
Current: $23.72
Upside: +1.18%
May 6, 2026
Maintained: Buy
Price Target: $188
Current: $164.18
Upside: +14.51%
May 5, 2026
Maintained: Hold
Price Target: $466
Current: $480.18
Upside: -2.95%
Apr 30, 2026
Maintained: Hold
Price Target: $83 → $86
Current: $78.34
Upside: +9.78%
Apr 4, 2026
Maintained: Buy
Price Target: $214
Current: $201.96
Upside: +5.96%
Apr 4, 2026
Maintained: Buy
Price Target: $12
Current: $1.71
Upside: +601.75%
Apr 2, 2026
Maintained: Buy
Price Target: $33
Current: $25.30
Upside: +30.43%
Mar 29, 2026
Maintained: Buy
Price Target: $41
Current: $24.73
Upside: +65.79%
Mar 27, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $30.97
Upside: +29.16%
Mar 25, 2026
Reiterated: Buy
Price Target: $11 → $14
Current: $13.58
Upside: +3.09%
Mar 6, 2026
Reiterated: Buy
Price Target: $32
Current: $25.34
Upside: +26.28%
Feb 13, 2026
Maintained: Hold
Price Target: $1
Current: $0.6166
Upside: +62.18%
Feb 12, 2026
Reiterated: Buy
Price Target: $508 → $444
Current: $293.17
Upside: +51.45%
Dec 22, 2025
Rated: Hold
Price Target: n/a
Current: $1.85
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
Dec 15, 2025
Maintained: Buy
Price Target: $39 → $36
Current: $20.61
Upside: +74.67%
Sep 19, 2024
Rated: Hold
Price Target: n/a
Current: $8.55
Upside: n/a
Jun 3, 2023
Maintained: Buy
Price Target: $5
Current: $12.66
Upside: n/a
May 12, 2022
Reiterated: Hold
Price Target: $3
Current: $5.75
Upside: n/a
Feb 28, 2022
Downgraded: Hold
Price Target: $11 → $20
Current: $70.16
Upside: n/a
Aug 16, 2017
Initiated Coverage: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $14 → $20
Current: $0.0001
Upside: n/a
Nov 23, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.45
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.87
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: $29
Current: $17.39
Upside: n/a
May 19, 2016
Maintained: Buy
Price Target: $11
Current: $0.0004
Upside: n/a
May 6, 2016
Reiterated: Hold
Price Target: $14 → $7
Current: $1.05
Upside: n/a